Your browser doesn't support javascript.
loading
Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies.
Ross, J A; Spadaro, M; Rosado, D C; Cavallo, F; Kirken, R A; Pericle, F.
Affiliation
  • Ross JA; 1] Department of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, USA [2] El Paso Children's Hospital, El Paso, TX, USA.
  • Spadaro M; Molecular Biotechnology Center, University of Turin, Turin, Italy.
  • Rosado DC; Department of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, USA.
  • Cavallo F; Molecular Biotechnology Center, University of Turin, Turin, Italy.
  • Kirken RA; Department of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, USA.
  • Pericle F; Division of Targeted Therapeutics, EP Pharma, Inc., El Paso, TX, USA.
Leukemia ; 28(4): 941-4, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24153015
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Cycloparaffins / Protein Kinase Inhibitors / Janus Kinase 3 / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Ketones Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Cycloparaffins / Protein Kinase Inhibitors / Janus Kinase 3 / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Ketones Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States